Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor γ Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End Products-Reference-Cited by-同舟云学术

Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor γ Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End Products

Published:2013-06-12 Issue:6 Volume:8 Page:e66611
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chen Ying Ju,Sheu Meei Ling,Tsai Keh Sung,Yang Rong Sen,Liu Shing Hwa

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Osteoarthritis;GG Glass;Dis Mon,2006

2. Osteoarthritis;MB Goldring;J Cell Physiol,2007

3. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis;M Blagojevic;Osteoarthritis Cartilage,2010

4. An update on the epidemiology of knee and hiposteoarthritis with a view to prevention;DT Felson;Arthritis Rheum,1998

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-708–5p deficiency involves the degeneration of mandibular condylar chondrocytes via the TLR4/NF-κB pathway;Osteoarthritis and Cartilage;2024-06

2. Retraction: Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor γ Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End Products;PLOS ONE;2024-05-01

3. Correction: Belief about the future possibility of national aging security system and its association with mortality;PLOS ONE;2024-05-01

4. Advanced glycation end products promote meniscal calcification by activating the mTOR-ATF4 positive feedback loop;Experimental & Molecular Medicine;2024-03-01

5. Senescence-regulatory factors as novel circulating biomarkers and therapeutic targets in regenerative medicine for osteoarthritis;Joint Bone Spine;2024-03